XRN2 interactome reveals its synthetic lethal relationship with PARP1 inhibition

dc.contributor.authorPatidar, Praveen L.
dc.contributor.authorViera, Talysa
dc.contributor.authorMorales, Julio C.
dc.contributor.authorSingh, Naveen
dc.contributor.authorMotea, Edward A.
dc.contributor.authorKhandelwal, Megha
dc.contributor.authorFattah, Farjana J.
dc.contributor.departmentBiochemistry and Molecular Biology, School of Medicineen_US
dc.date.accessioned2021-05-11T20:22:42Z
dc.date.available2021-05-11T20:22:42Z
dc.date.issued2020-08-28
dc.description.abstractPersistent R-loops (RNA–DNA hybrids with a displaced single-stranded DNA) create DNA damage and lead to genomic instability. The 5′-3′-exoribonuclease 2 (XRN2) degrades RNA to resolve R-loops and promotes transcription termination. Previously, XRN2 was implicated in DNA double strand break (DSB) repair and in resolving replication stress. Here, using tandem affinity purification-mass spectrometry, bioinformatics, and biochemical approaches, we found that XRN2 associates with proteins involved in DNA repair/replication (Ku70-Ku80, DNA-PKcs, PARP1, MCM2-7, PCNA, RPA1) and RNA metabolism (RNA helicases, PRP19, p54(nrb), splicing factors). Novel major pathways linked to XRN2 include cell cycle control of chromosomal replication and DSB repair by non-homologous end joining. Investigating the biological implications of these interactions led us to discover that XRN2 depletion compromised cell survival after additional knockdown of specific DNA repair proteins, including PARP1. XRN2-deficient cells also showed enhanced PARP1 activity. Consistent with concurrent depletion of XRN2 and PARP1 promoting cell death, XRN2-deficient fibroblast and lung cancer cells also demonstrated sensitivity to PARP1 inhibition. XRN2 alterations (mutations, copy number/expression changes) are frequent in cancers. Thus, PARP1 inhibition could target cancers exhibiting XRN2 functional loss. Collectively, our data suggest XRN2’s association with novel protein partners and unravel synthetic lethality between XRN2 depletion and PARP1 inhibition.en_US
dc.identifier.citationPatidar, P. L., Viera, T., Morales, J. C., Singh, N., Motea, E. A., Khandelwal, M., & Fattah, F. J. (2020). XRN2 interactome reveals its synthetic lethal relationship with PARP1 inhibition. Scientific Reports, 10(1), 14253. https://doi.org/10.1038/s41598-020-71203-7en_US
dc.identifier.issn2045-2322en_US
dc.identifier.urihttps://hdl.handle.net/1805/25929
dc.language.isoen_USen_US
dc.publisherNature Publishing Groupen_US
dc.relation.isversionof10.1038/s41598-020-71203-7en_US
dc.relation.journalScientific Reportsen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourcePMCen_US
dc.subjectCanceren_US
dc.subjectCell biologyen_US
dc.subjectMolecular biologyen_US
dc.titleXRN2 interactome reveals its synthetic lethal relationship with PARP1 inhibitionen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
41598_2020_Article_71203.pdf
Size:
3.14 MB
Format:
Adobe Portable Document Format
Description:
Main article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: